The Elastomeric infusion pumps are non-electric, disposable pumps that provide the fluids such as antibiotics, analgesics, and chemotherapy drugs, in a patient’s body in controlled quantity. The elastomeric infusion pump comprises of the elastomeric layer which delivers the required compression for administrating the drug. These pumps deliver the advanced benefits over conventional infusion pumps in advantages such as portability, feasibility, and less scope for human errors. In addition, such pumps do not demand electricity and action of gravity. Moreover, it can be utilized for a variable duration ranging from a few minutes to numerous days. There are two forms of the elastomer infusion pumps that involve the continuous rate pumps, and variable rate pumps.
According to the report analysis, ‘Elastomer Infusion Pump Market by Product (Continuous Rate Pumps, Variable Rate Pumps), Application (Pain Management, Infection Management, Chemotherapy, and Others), and End User (Hospitals and Clinics, Ambulatory Care, and Home Care): Global Opportunity Analysis and Industry Forecast, 2019-2026’ states that in the elastomer infusion pump the market there are several corporates which presently operating more actively for leading the fastest market growth and registering the great value of the market share around the globe throughout the inflowing years while implementing the profitable strategies, analyzing the policies of the competitors, spreading the awareness related to the elastomer infusion pump, developing the applications and features of such, advancing the specifications of the production technologies, decreasing the linked price and delivering better consumer satisfaction includes B Braun Melsungen Ag, Baxter International Inc., Halyard Health, Heka Healthcare, Nipro Medical Corporation (Nipro Medical Europe NV), Palex Medical SA, Pfizer Inc. (Hospira Inc.), Pfm Medical Ag, PROMECON GmbH and several others.
The worldwide elastomer infusion pump market was worth at USD 534 million in 2018, and is projected to reach at USD 745 million by 2026, dominating a CAGR of 4.2% from 2019 to 2026.
In addition, the effective increase in the demand for the small disposable elastomer infusion pump, owing to its long term home care a rehabilitation program, increase in the pervasiveness of chronic diseases, growth inaccessibility of elastomer infusion pumps, technological advancement of the novel elastomeric infusion pumps are the foremost factors that influence the growth of the elastomer infusion pump market. Not only has this, post-operative pain in surgeries such as total hip replacement and total knee replacement is frequently treated by the infusion of analgesics through elastomer infusion pumps. Therefore, momentous increase in the number of orthopedic procedures & surgeries is projected to propel the growth of the market.
For instance, according to the American Academy of Orthopedic Surgeons Annual report in 2018, nearly 1 million patients and over 1.4 million hip & knee arthroplasty procedures & surgeries were accounted into the American Joint Replacement Registry. Moreover, the elastomer infusion pumps have fewer adversative effects as associated with electronic pumps and are less costly, which propels their implementation in ambulatory chemotherapy and analgesic infusion centers. Additionally, elastomer infusion pumps are accessible in small size, lightweight, disposable, and eradicate programming errors. Such recompenses of elastomer infusion pumps over the conventional electric infusion pump are projected to drive the growth of the market. Therefore, in the near years, it is predicted that the market of elastomeric infusion pumps will increase around the globe over the inflowing years more effectively.
For More Information on the Research Report, refer to below links: –
Related Report: –
Contact Us: –
Ankur Gupta, Head Marketing & Communications